← Open Payments lookup

RITA LUTZ: Open Payments

NPI 1982195285 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,127 in 219 payments from 23 companies in 2025. Trend: 2023 $3,318 · 2024 $4,730 · 2025 $4,127

Food & beverage: $4,050Education: $77
CompanyPaymentsAmount
ABBVIE INC.46$864
Janssen Biotech, Inc.18$440
Aimmune Therapeutics, Inc.23$435
Salix Pharmaceuticals, a division of Bausch Health US, LLC19$363
Takeda Pharmaceuticals U.S.A., Inc.19$260
Ardelyx, Inc.14$256
Madrigal Pharmaceuticals9$229
Gilead Sciences, Inc.25$206
Celltrion USA Inc.9$193
Lilly USA, LLC6$175

Products named: TREMFYA, ZENPEP, XIFAXAN, RINVOQ, IBSRELA, ENTYVIO, REZDIFFRA, LINZESS.

Industry payments across MO — which companies pay providers there.